Changes in the enzymatic activity of glutathione S-transferases from human peripheral blood lymphocytes after the action of cis-and trans-diamminedichloroplatinum (II)

Acta Biologica Cracoviensia Series Zoologia

Volumn 43, Issue , 2001, Pages 23-29

  Walter, Zofia ^a   Kargas, Christos ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Cis diamminedichloroplatinum (CDDP); Glutathione S transferases (GST); Human lymphocytes; Trans diamminedichloroplatinum (TDDP); Viability

Indexed keywords

EID: 12444325580     PISSN: 0001530X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ARAI, T., Y. YASUDA, Y. ITO, K. HAYAKAWA, T. TAKAYA, S. TOSHIMA, C. SHIBUYA, M. NAWADA, M. SHIBAYAMA, N. YOSHIMI, H. ITO, and H. FUJIWARA. 1996. Correlation between an enzyme (glutathione S-transferase-pi) and effects of chemotherapy. Gau To Kagaku Ryoto 23: 881-885.
2. BAN, N., Y. TAKAHASHI, T. TAKAYAMA, T. KURA, T. KATAHIRA, S. SAKAMAKI, and Y. NIITSU. 1996. Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide. Cancer Res. 56: 3577-3582.
3. BEKETIC-ORFESKOVIC, L., M. OSMAN, and M. JAKSISK. 1994. Human larynx carcinoma cells resistant to cis- diamminedichloro-platinum (II): mechanisms involved in the resistance. Neoplasma 41: 163-169.
4. BRADFORD, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
5. BUZAID, A. C., F. ALI-OSMAN, N. AKANDE, E. A. GRIMM, J. J. LEE, A. BEDIKIAN, O. ETON, N. PAPADOPULOS, C. PLAGER, S. S. LEGHA, and R. S. BENJAMIN. 1998. DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma. Melanoma Res. 8: 145-148.
6. CHAO, C. C., Y. T. HUANG, C. M. MA, W. Y. CHOU, and S. LIN-CHAO. 1992. Overexpression of glutathione S-transferase and elevation of thiol pools in a multidrug resistant human colon cancer cell line. Mol. Pharmacol. 41: 69-75.
7. COLE, S. P., H. F. DOWNES, S. E. MIRSKI, and D. J. CLEMENTS. 1990. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line. Mol. Pharmacol. 37: 192-197.
8. CZERSKI, P. S. SZMIGIELSKI, and J. LITWIN. 1966. Simple methods for obtaining purified suspensions of lymphocytes. Vox. Sang. 11: 734-737.
9. EASTMAN, A. 1985. Interstrand cross-links and sequence specificity in the reaction of cis- dichloro (ethylenediamine) platinum (II) with DNA. Biochemistry 24: 5027-5032.
10. EASTMAN, A., and M. A. BARRY. 1987. Interaction of trans- diamminedichloroplatinum (II) with DNA: formation of monofunctional adducts and their reaction with glutathione. Biochemistry 26: 3303-3307.
11. GODWIN, A. K., A. MEISTER, P. J. O'DWYER, C. S. HUANG, T. C. HAMILTON, and M. E. ANDERSON. 1992. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 89: 3070-3074.
12. GOTO, S., T. IIDA, S. CHO, M. OKA, S. KOHNO, and T. KONDO. 1999. Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic. Res. 31: 549-558.
13. HABIG, W. H., and W. B. JAKOBY. 1981. Assays for differentiation of glutathione S-transferases. Methods Enzymol. 77: 398-405.
14. HABIG, W. H., M. J. PABST, and W. B. JAKOBY. 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249: 7130-7134.
15. HOFS, H. P., T. D. J. WAGNER, V. DE VALK-BAKKER, H. VAN RENNES, W. H. DOESBURG, H. C. J. OTTENHEIJM, and W. J. DE GRIP. 1997. The effect of ethyldehydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity. Anticancer Drugs 8: 349-357.
16. HUANG, J. C., D. B. ZAMBLE, J. T. REARDON, S. J. LIPPARD, and A. SANCAR. 1994. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. USA 91: 10394-10398.
17. JAKOBY, W. B. 1985. Glutathione transferases: an overview. Methods Enzymol. 113: 495-499.
18. KATOH, S., S. NAITO, A. YOKOMIZO, K. KOHNO, and J. KUMAZAWA. 1997. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype. J. Urol. 157: 1054-1058.
19. KODERA, Y., S. AKIYAMA, K. ISOBE, K. KONDO, K. ITO, M. YAMAUCHI, and H. TAKAGI. 1994. Expression of pi-glutathione S-transferase gene (GSTP1) in gastric cancer: lack of correlation with resistance against cis-diamminedichloroplatinum (II). Eur. J. Cancer 30A: 2158-2162.
20. LEYLAND-JONES, B. R., A. J. TOWNSEND, C. P. TU, K. H. COWAN, and M. E. GOLDSMITH. 1991. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene. Cancer Res. 51: 587-594.
21. MATSUMOTO, M., M. IMAGAWA, and Y. AOKI. 2000. Epidermal growth factor regulation of glutathione S-transferase gene expression in the rat is mediated by class Pi glutathione S-transferase enhancer I. Biochem. J. 349: 225-230.
22. MC LELLAN, L. I., C. R. WOLF, and J. D. HAYES. 1989. Human microsomal glutathione S-transferase. Its involvement in the conjugation of hexachlorobuta-1,3-diene with glutathione. Biochem. J. 258: 87-93.
23. MEYER, D. J., and M. THOMAS. 1995. Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase. Biochem. J. 311: 739-742.
24. MIRABELLI, C. K., C. SUNG, J. P. ZIMMERMAN, D. T. HILL, S. MONG, and S. T. CROOKE. 1986. Interactions of gold coordination complexes with DNA. Biochem. Pharmacol. 35, 1427-1433.
25. MISTRY, P., L. R. KELLAND, G. ABEL, S. SIDHAN, and K. R. HARRAP. 1990. The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br. J. Cancer 64: 215-220.
26. MULDER, T. P., J. J. MANNI, H. M. ROELOFS, W. H. PETERS, and A. WIERSMAN. 1995. Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis 16: 619-624.
27. MULLER, M., J. MEIJER, G. J. R. ZAMAN, P. BORST, R. J. SCHEPER, N. H. MULLER, E. G. E. DE VRIES, P. L. M. and JANSEN. 1994. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc. Natl. Acad. Sci. USA 91: 13033-13037.
28. NAGANE, M., A. ASAI, S. SHIBAI, H. OYAMA, K. NOMURA, and Y. KUCHINO. 1999. Expression pattern of chemoresistance-related genes in human malignant brain tumors: a working knowledge for proper selection of anticancer drugs. Jpn. J. Clin. Oncol. 29: 527-534.
29. NAKAGAWA, K., J. YOKOTA, M. WADA, Y. SASAKI, Y. FUJIWARA, M. SAKAI, M. MURAMATSU, T. TERASAKI, Y. TSUMOKAWA, M TERADA. 1988. Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn. J. Cancer Res. 79: 301-304.
30. OGUCHI, H., F. KIKKAWA, M. KOJIMA, O. MAEDA, K. MIZUNO, N. SUGANUMA, M. KAWAI, and Y. TOMODA. 1994. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and resistant human ovarian carcinoma cells. Anticancer Res. 14:193-200.
31. OKUYAMA, T., Y. MAEHARA, K. ENDO, H. BABA, Y. ADACHI, M. KUWANO, and K. SUGIMACHI. 1994. Expression of glutathione S-transferase-pi and sensitivity of human gastric cancer cells to cisplatin. Cancer 74: 1230-1236.
32. ORIDATE, N., S. NISHI, Y. INUYAMA, and M. SAKAI. 1994. Jun and Fos related gene products bind to and modulate the GPE1, a strong enhancer element of the rat glutathione transferase P gene. Biochim. Biophys. Acta 1219: 499-504.
33. PEMBLE, S. E., A. F. WARDLE, and J. B. TAYLOR. 1996. Glutathione S-transferase class Kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem. J. 319: 749-754.
34. POIRIER, M. C., E. REED, L. A. ZWELLING, R. F. OZOLS, C. C. LITTERST, and S. H. YUSPA. 1985. Polyclonal antibodies to quantitate cis-diamminedichloroplatinum (II) DNA adducts in cancer patients and animal models. Environ. Health Perspect. 62: 89-94.
35. PUCHALSKI, R. B., and W. E. FAHL. 1990. Expression of recombinant glutathione S-transferase pi, Ya, or Yb1 confers resistance to alkylating agents. Proc. Natl. Acad. Sci. U.S.A. 87: 2443-2447.
36. SABURI, Y., M. NAKAGAWA, M. ONO, M. SAKAI, M. MURAMATSU, K. KOHNO, and M. KUWANO. 1989. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum (II) resistant variants of a Chinese hamster ovary cell line. Cancer Res. 49: 7020-7025.
37. SCANLON K. I., M. KASHANI-SABET, T. TONE, and T. FUNATO. 1991. Cisplatin resistance in human cancers. Pharmacol. Ther. 52: 385-406.
38. SHARMA, R., S. S. SINGHAL, J. K. SRIVASTAVA, K. K. BAJPAI, E. P. FRENKEL, and S. AWASTHI. 1993. Glutathione and glutathione linked enzymes in human small cell lung cancer cell lines. Cancer Lett. 75: 111-119.
39. SHEEHAN., and G. MEADE. 2000. Chemical modulation of chemotherapy resistance in cultured esophageal carcinoma cells. Biochem. Soc. Trans. 28: 27-32.
40. TEW, K. D. 1994. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54: 4313-4320.
41. TIMMER-BOSSCHA, H., A. TIMMER, C. MEIJER, E. G. DE VRIES, DE B. JONG, J. W. OOSTERHKIS, and N. H. MULDER. 1993. cis-diamminedichloroplatinum (II) resistance in vitro and in vivo in human embryonal carcinoma cells. Cancer Res. 53: 5707-5713.
42. TOMINAGA, K., T. ARAKAWA, M. IMANO, M. KATO, Y. HAMAGUCHI, T. WATANABE, O. TAKAISHI, Y. FUJIWARA, T. FUKUDA, K. HIGUCHI, H. OSUGI, S. CHONO, and T. KUROKI. 1999. Complete regression of recurrent esophageal carcinoma with reduced expression of glutathione S-transferase-pi by treatment with continuous infusion of 5-fluorouracil and low-dose cisplatin infusion. Am. J. Gastroenterol. 94: 1664-1668.
43. TRAKSHEL, G. M., and M. D. MAINES. 1998. Characterization of glutathione S-transferases in rat kidney. Alteration of composition by cis- platinum. Biochem. J. 252: 127-136.
44. TWENTYMAN, P. R. 1997. Transport proteins in drug resistance: biology and approaches to circumvention. J. Intern. Med. Suppl. 740: 133-137.
45. YELLIN, S. A., B. J. DAVIDSON, J. T. PINTO, P. G. SACKS, C. QIAO, and S. P. SCHANTZ. 1994. Relationship of glutathione and glutathione-S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer Lett. 85: 223-232.
46. WANG, Y. Y., B. A. TEICHER, T. C. SHEA, S. A. HOLDEN, K. W. ROSBE, A. AL-ACHI, and W. D. HENNER. 1989. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res. 49: 6185-6192.
47. WALTER, Z., and M. SPYCHAŁA. 1991. The effect of cis- diamminedichloroplatinum (II) on the formation of DNA-Pt-DNA cross links. Acta Biochim. Pol. 38: 95-99.
48. WALTER, Z. 1994. Glutathione S-transferases. In: Z. Kiliańska, W. M. Krajewska and A. Lipińska [eds.], Proteins of normal and pathological cells, 151-171. Łódzkie Towarzystwo Naukowe, Łódź.
49. WALTER, Z., M. GRABOWSKA, and I. MAJSTEREK. 1998. Binding of the anticancer drug cis-diamminedichloroplatinum (II) to mammalian mitochondrial DNA. Acta Biol. Cracov. Ser. Zool. 40: 69-73.
50. WELTERS, M. J., A. M. FICHTINGER-SCHEPMAN, R. A. BAAN, M. J. FLENS, R. J. SCHEPER, and B. J. BRAAKHUIS. 1998. Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines. Br. J. Cancer 77: 556-561.
51. WOŹNIAK K., and Z. WALTER. 2000. Induction of DNA-Protein cross-links by platinum compounds. Z. Naturforch 55C: 731-736.
52. XU, X., and P. J. STAMBROOK. 1994. Two murine GST pi genes are arranged in tandem and are differentially expressed. J. Biol. Chem. 269: 30268-30273.